A Pharmacotherapeutic controlled study to evaluate the Efficacy of Shweta Aparajita root Clitoria ternatea Linn. in Arka dosage form as add on along with Thyroxine in the management of Galganda i.e. Primary Hypothyroidism. - NI

Dr Jayshree Hadke0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•Patients between the age group of 25-50 years & of any Gender.
•Patients who are already diagnosed as Primary Hypothyroidism and under Thyroxine
•medication and within six months of Diagnosis and newly diagnosed cases.
•Patients who are willing and sign the informed consent form.

•Patient suffering from systemic disease like Cardiac Disorder/Diabetes
•Mellitus/COPD/TB/HIV/HCV/HBsAg
•Immuno-compromised patients.
•Pregnancy and lactating mother and Renal insufficiency.
•Patient who are known case of Congenital Hypothyroidism, Hypopitutarism, Secondary
•Hypothyroidism, Thyroid, Neoplasia & Progressive cases of Myxedema coma.
•Any serious medical and psychological condition will be excluded.
•Malabsorption disorders
•Concomitant use of drugs such as multivitamins, minerals, phenobarbital, phenytoin,
•carbamazepine, rifampin, glucocorticoids, warfarin, statins, estrogen, and raloxifene.

发起方

Dr Jayshree Hadke